(Q50985567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

McLennan SV

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Schache M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Waltham M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dy V

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Langham RG

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Yue DK

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Gilbert RE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

6 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

481-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17554258%20AND%20SRC:MED&resulttype=core&format=json

Structural-functional correlations of diabetic nephropathy

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Role of matrix metalloproteinases in renal pathophysiologies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Effect of glucose on matrix metalloproteinase activity in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Matrilysin in epithelial repair and defense.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Polyantigenic expansion of basement membrane constituents in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021

Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002357

7 January 2021